Pediatric Liver Tumors

  • Marleta Reynolds
Part of the Cancer Treatment and Research book series (CTAR, volume 109)


In children, 70% of primary hepatic neoplasms are malignant. The liver is the 3rd most common site of intraabdominal malignancy following Wilms’ tumor and neuroblastoma. Malignant hepatic neoplasms are the 10th most common pediatric malignancy affecting 1.6 per million in the United States. (0.9 per million children with hepatoblastoma and 0.7 per million children with hepatocellular carcinoma) (1). Secondary hepatic malignancies are most common in children with Wilms’ tumor, neuroblastoma and leukemia. Benign liver tumors are rare and most occur in infants [Table I] .


Biliary Atresia Hepatic Tumor Abdominal Mass Focal Nodular Hyperplasia Alpha Feto Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bowman LC, Riely CA. Management of pediatric liver tumors (Review). Surg Oncol Clin North Am 1996; 5:451–459.Google Scholar
  2. 2.
    Selby DM, Stocker JT,Waclawiw MA et al: Infantile hemangioendothelioma of the liver. Hepatology 1994; 20:39–45.PubMedGoogle Scholar
  3. 3.
    Daller JA, Bueno J, Gutierrez J, et al. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg 1999; 34(1): 98–106.PubMedCrossRefGoogle Scholar
  4. 4.
    Abramson SJ, Lack EE, Teele RL. Benign vascular tumors of the liver in infants: Sonographic appearance. AJR 1982; 138 :629–632.PubMedCrossRefGoogle Scholar
  5. 5.
    Smith WL, Franken EA, Mitros WJ. Liver tumors in children. Semin Roentgenol 1983;18:136–148.PubMedCrossRefGoogle Scholar
  6. 6.
    Lucaya J, Enriquez G, Amat L. et al. Computed tomography of infantile hemangioendothelioma. AJR 1977; 144:821–826.CrossRefGoogle Scholar
  7. 7.
    von Schweinitz D, Gluer S, Mildenberger H. Liver tumors in neonates and very young infants: diagnostic pitfalls and therapeutic problems. Eur J Pediatr Surg 1995; 5:72–76.CrossRefGoogle Scholar
  8. 8.
    Davenport M, Hansen L, Heaton ND, Howard ER. Hemangioendothelioma of the liver in infants. J Pediatr Surg 1995;30:44–48.PubMedCrossRefGoogle Scholar
  9. 9.
    Samuel M, Spitz L. Infantile hepatic hemangio-endothelioma: the role of surgery. J Pediatr Surg 1995;30:1425–1429.PubMedCrossRefGoogle Scholar
  10. 10.
    Woltering MD, Robben S, Egeler RM. Hepatic hemangioendothelioma of infancy: treatment with interferon alpha. J Pediatr Gastroenterol Nutr 1997;24:348–351.PubMedCrossRefGoogle Scholar
  11. 11.
    Fok TF, Chan MS, Metreweli C, et al. Hepatic hemangioendothelioma presenting with early heart failure in a newborn: treatment with hepatic artery embolization and interferon. Acta Paediatr 1996;85:1373–1375.PubMedCrossRefGoogle Scholar
  12. 12.
    Achilleos OS, Buist LJ, Kelly DA, et al. Unresectable hepatic tumors in childhood and the role of liver transplantation. J Pediatr Surg 1996;31:1563–1567.PubMedCrossRefGoogle Scholar
  13. 13.
    Weinberg AG, Finegold MJ. Primary hepatic tumors in childhood [Review] . Human Pathol 1983;14:512–537.CrossRefGoogle Scholar
  14. 14.
    Craig JR, Peters RL, Edmondson HA. Tumors of the liver and extrahepatic bile ducts. AFIP, Bethesda, MD., pp. 63–64, 190–197, 1989.Google Scholar
  15. 15.
    Williams RA, Ferrell LD. Pediatric liver tumors. Pathology 1993;2:23–42.PubMedGoogle Scholar
  16. 16.
    Mann JR, Kasthuri N, Raafat F, et al. Malignant hepatic tumors in children: incidence, clinical features and etiology. Paediatr Perinat Epidemiol 1990:4:276–289.PubMedCrossRefGoogle Scholar
  17. 17.
    Giardiello FM, Offerhaus JA, Krush AJ, et al. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 1991;119:766–768.PubMedCrossRefGoogle Scholar
  18. 18.
    Stocker JT. Hepatoblastorna. Semin Diagn Pathol 1994;11:136–143.PubMedGoogle Scholar
  19. 19.
    Tanimira M, Matsui I, Abe J, et al. Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Research 1998;58:3032–3035.Google Scholar
  20. 20.
    Raney B. Hepatoblastoma in children: a review. J Pediatr Hematol Oncol 1997;19:418–422.PubMedCrossRefGoogle Scholar
  21. 21.
    von Schweinitz D, Hecker H, Harms D, et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma - a report from the German Cooperative Liver Tumor Study HB-89. J Pediatr Surg 1995;30:845–852.CrossRefGoogle Scholar
  22. 22.
    Hata Y, Ishizu H, Ohmori K, et al. Flow cystometric analysis of the nuclear DNA content of hepatoblastoma. Cancer 1991;68:2566–2570.PubMedCrossRefGoogle Scholar
  23. 23.
    Boechat MJ, Kangarloo H, Ortega J, et al. Primary liver tumors in children: comparison of CT and MR imaging. Radiology 1988;169:727–732.PubMedGoogle Scholar
  24. 24.
    Finn JP, Hall-Craggs MA, Dicks-Mireaux C, et al. Primary malignant liver tumors in children: assessment of resectability with high fiield MR and comparison with CT. Pediatr Radiology 1990;21:34–38.CrossRefGoogle Scholar
  25. 25.
    King SJ, Babyn PS, Greenberg ML, et al. Value of CT in determining resectability of hepatoblastoma before and after chemotherapy. AJR 1993;160:793–798.PubMedCrossRefGoogle Scholar
  26. 26.
    Vos A. Primary liver tumors in children. Eur J Surg Oncol 1995;21:101–105.PubMedCrossRefGoogle Scholar
  27. 27.
    Reynolds M, Douglass E, Finegold M, et al. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992;27:1080–1084.PubMedCrossRefGoogle Scholar
  28. 28.
    Ehrlich P, Greenberg M, Filler R. Improved long-term survival with preoperative chemotherapy for hepatoblastoma. J Pediatr Surg 1997;32:999–1003.PubMedCrossRefGoogle Scholar
  29. 29.
    Ortega JA, Douglass E, Feussner J, et al. A randomized trial of Cisplatin, Vincristine, 5 Fluorouracil vs Cisplatin, Doxorubicin IV continuous infusion for the treatment of hepatoblastoma: results from the Pediatric Intergroup Hepatoma Study,(CCG8881/POG8945). Proc Am Soc Clin Oncol 1994;13:416.Google Scholar
  30. 30.
    Oue T, Fukuzawa M, Kusafuka T, et al. Trancatheter arterial chemoembolization in the treatment of hepatoblastoma. J Pediatr Surg 1998;33 (12):1771–1775.PubMedCrossRefGoogle Scholar
  31. 31.
    Yoshinari M, Imaizumi M, Hayashi Y, et al. Peripheral blood stem cell transplantation for hepatoblastoma with microscopic residual: a therapeutic approach for incompletely resected tumor. Tohoku J ExpMed 1998;184:247–254.CrossRefGoogle Scholar
  32. 32.
    Von Tornout JM, Buckley JD, Quinn JJ. Timing and magnitude of decline in alpha feto protein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children’s Cancer Group. J Clin Oncol 1997;15 :1190–1197.PubMedGoogle Scholar
  33. 33.
    Black CT, Luck SR, Musemeche CA, Andrassy RJ. Aggressive excision of pulmonary metastasis is warranted in the management of childhood hepatic tumors. J Pediatr Surg 1991;26:1082–1086.PubMedCrossRefGoogle Scholar
  34. 34.
    Passmore SJ, Noblett HR, Wisheart JD, Mott MG. Prolonged survival following multiple thoracotomies for metastatic hepatoblastoma. Med Pediatr Oncol 1995;24:58–60.PubMedCrossRefGoogle Scholar
  35. 35.
    Feussner J, Krailo M, Haas J, et al. Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Children’s Canger Group. Cancer 1993;71:859–863.CrossRefGoogle Scholar
  36. 36.
    Koneru B, Flye M, Busuttil R, et al. Liver transplantation for hepatoblastoma: the American experience. Ann Surg 1991;213 :118–121.PubMedCrossRefGoogle Scholar
  37. 37.
    Tagge E, Tagge D, Reyes J, et al. Resection, including transplantation for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 1992;27:292–297.PubMedCrossRefGoogle Scholar
  38. 38.
    Bilik R, Superina R. Transplantation for unresectable liver tumors in children. Transplant Proc 1997;29:2834–2835.PubMedCrossRefGoogle Scholar
  39. 39.
    Busuttil R, Farmer D. The surgical treatment of primary hepatobiliary malignancy. Liver Transplant Surg 1996;2(5 Supp 1):114–130.Google Scholar
  40. 40.
    Ammann R, Plaschkes J, Leibundgut K. Congenital hepatoblastoma: A distinct entity? Med & Pediatr Oncol 1999; :466–468.Google Scholar
  41. 41.
    Newman KD. Hepatic tumors in children. Semin Pediatr Surg 1997;6: 38–41.PubMedGoogle Scholar
  42. 42.
    Douglass E, Ortega J, Feusner J, et al. Hepatocellular carcinoma (HCA) in children and adolescents. Results from the Pediatric Intergroup Study (CCG8881/POG 8945). Proc Am Soc Clin Oncol 1994;13:420 (Abstract 1439).Google Scholar
  43. 43.
    Awan S, Davenport M, Portmann B, Howard ER. Angiosarcoma of the liver in children. J Pediatr Surg 1996;31:1729–1732.PubMedCrossRefGoogle Scholar
  44. 44.
    Babin-Boilletot A, Flamant F, Terrien-Lacombe MJ, et al. Primitive malignant nonepithelial hepatic tumors in children. Med Pediatr Oncol 1993;21:634–639.PubMedCrossRefGoogle Scholar
  45. 45.
    Jimenez-Hefferman JA, Lopez-Ferver P, Burgos E, Viguer JM. Pathological case of the month: primary malignant tumor with rhabdoid features. Archiv Ped & Adolesc Med 1998;152(5):509–510.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2001

Authors and Affiliations

  • Marleta Reynolds
    • 1
  1. 1.Children’s Memorial HospitalChicagoUSA

Personalised recommendations